| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_88f0c5d39781ff6ab02541a3ff23f808 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 |
| filingDate |
2015-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b30fae209656e8aec3851431e7c788ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a42185526f6b853ad2d3497b5d880f68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_baa758968fe4cf8665525e430d83caa2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7cd3c01c37b3f5193805a44f675e845
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4bd6dc484f84297a9ca91b9f07792d13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2be9c4fb3120c58fc2665741dd81e9a3 |
| publicationDate |
2017-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20170013866-A |
| titleOfInvention |
(5,6-dihydro)pyrimido[4,5-e]indolizines |
| abstract |
The present invention relates to compounds of formula (I) Formula I In the formula (I) R 1 and R 2 are independently selected from the group consisting of optionally substituted (6-10C) aryl and (1-5C) heteroaryl groups. The compounds may be used in pharmaceutical compositions, particularly in the treatment of cancer. |
| priorityDate |
2014-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |